Response to locoregional treatment and alpha-fetoprotein trend in liver transplant candidates for HCC: Dwarfs standing on the shoulders of giants

Journal of Hepatology

Volumn 60, Issue 6, 2014, Pages 1331-1332

  Lai, Quirino ^a,b   Avolio, Alfonso W ^c   Graziadei, Ivo ^d   Lerut, Jan ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b POLICLINICO UMBERTO I   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ARTIFICIAL EMBOLISM; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOEMBOLIZATION; RADIOFREQUENCY ABLATION; REPEAT PROCEDURE; TREATMENT RESPONSE; CLINICAL PRACTICE; DISEASE COURSE; LIVER GRAFT; CARCINOMA, HEPATOCELLULAR; FEMALE; LIVER NEOPLASMS; MALE;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE;

EID: 84901194902     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.01.030     Document Type: Letter

References (10)

1. G. Otto, M. Schuchmann, M. Hoppe-Lotichius, M. Heise, A. Weinmann, and T. Hansen et al. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? J Hepatol 59 2013 279 284
2. A. Paul, G. Sotiropoulos, G. Gerken, and F.H. Saner How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? J Hepatol 60 2014 463 464
3. Q. Lai, A.W. Avolio, I. Graziadei, G. Otto, M. Rossi, and G. Tisone et al. Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation Liver Transpl 19 2013 1108 1118
4. P.A. Clavien, M. Lesurtel, P.M. Bossuyt, G.J. Gores, B. Langer, and A. Perrier OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report Lancet Oncol 13 2012 e11 e22
5. I. Bargellini, E. Bozzi, D. Campani, P. Carrai, P. De Simone, and L. Pollina et al. Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants Eur J Radiol 82 2013 e212 e218
6. P.E. Majno, R. Adam, H. Bismuth, D. Castaing, A. Ariche, and J. Krissat et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 1997 688 701
7. N. Mehta, and F.Y. Yao Moving past "One size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantation Liver Transpl 19 2013 1055 1058
8. Q. Lai, A.W. Avolio, J. Lerut, G. Singh, S.C. Chan, and P.B. Berloco et al. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West J Hepatol 57 2012 974 979
9. Q. Lai, I. Graziadei, G. Otto, P. Goffette, P. Berloco, and G. Tisone et al. Alpha-fetoprotein increase and radiological progression as more refined clinical tools for a justified selection of HCC liver recipients Liver Transpl 19 2013 S118
10. A.N. Gordon-Weeks, A. Snaith, T. Petrinic, P.J. Friend, A. Burls, and M.A. Silva Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria Br J Surg 98 2011 1201 1208